Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novo Holdings

Novo Holdings
VC INVESTOR TYPE
Active STATUS
52 PROFESSIONALS
385 INVESTMENTS
112 PORTFOLIO
147 EXITS
Description

Founded in 1999, Novo Holdings is a corporate venture arm of the Novo Nordisk Foundation headquartered in Hellerup, Denmark. The firm is the holding company for the Novo Group. The firm seeks to invest in the biotechnology, healthcare and life sciences sectors.

Formerly Known As
Nova A/S
Investor Status
Actively Seeking New Investments
Year Founded
1999
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Real Estate
Venture Capital
Primary Office
  • Tuborg Havnevej 19
  • 2900 Hellerup
  • Denmark

+45 35 00 00 00

Novo Holdings Investments (385)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
HepaRegenix 21-Jan-2020 Early Stage VC 000.00 Drug Discovery Pre-Clinical Trials 0000000000 0000000000 00.0
00000000 000000000 08-Jan-2020 00000 00000 0000 Biotechnology Generating Revenue 0ø000 000000 00.0
000000000 07-Jan-2020 00000 00000 0000 Biotechnology Startup 0ø0000 0ø0000 00000000
0000000000 0000000 06-Jan-2020 00000 00000 00.00 Drug Discovery Product Development 00000 00000 00.0
000000000 06-Jan-2020 00 000000000 00.000 Biotechnology Generating Revenue 00000 00000 00.0
00000000 09-Dec-2019 00000 00000 00.000 Building Products Generating Revenue
000000000 00000000 20-Nov-2019 00000 00000 0000 Pharmaceuticals Stealth
0000-0000000000 00 14-Nov-2019 0000000000 00.000 Other Healthcare Services Generating Revenue
Allievex 23-Oct-2019 Early Stage VC 0000 Biotechnology Clinical Trials - Phase 2 0000 0000000 00.0
eResearch Technology 21-Oct-2019 PE Growth/Expansion Database Software Profitable 00000000000 0ø0000000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Novo Holdings’s full profile, request a free trial.

Novo Holdings Exits (145)

Company Name Exit Date Exit Type Exit Size Status Buyers
Reata Pharmaceuticals 14-Nov-2019 Public Investment 2nd Offering 00000 Completed
000000 00000000000 07-Nov-2019 000 0000 Completed
000000 000 11-Sep-2019 000000000000000000 Completed
  • 0000000
000 19-Aug-2019 000000000000000000 00.000 Completed
  • 000000 0000000000
00000 000000000000 18-Jul-2019 000 0000 Completed
  • 000000 0000000
000000000 01-Jul-2019 000000000000000000 00000 Completed
  • 000000
0000000 0000000000 27-Jun-2019 000 0000 Completed
000000 00000000000 31-May-2019 000000 0000000000 00000 Completed
Milestone Pharmaceuticals 13-May-2019 IPO 000.00 Completed
Affinicon 01-Feb-2019 Out of Business Completed
To view this investor’s complete exits history, request access »

Novo Holdings Team (108)

Name Title Deals Funds Boards Office Contact
Info
Kasim Kutay Chief Executive Officer 0 0 San Francisco, CA
Peter Haahr Chief Financial Officer & Member of the Management Board 0 Hellerup, Denmark
Morten Beck Jørgensen Managing Director, Financial Investments 0 0 Hellerup, Denmark
Søren Moller Ph.D Managing Partner, Novo Seeds 0 0 0 Hellerup, Denmark
Thomas Dyrberg MD Managing Partner, Novo Ventures 00 0 0 Hellerup, Denmark

36 Former Team Members

You’re viewing 5 of 108 team members. Get the full list »